Scientific Publications Database

Article Title: A Canadian Cancer Trials Group phase IB study of durvalumab plus tremelimumab given concurrently or sequentially in patients with advanced, incurable solid malignancies (IND.226)
Authors: Smoragiewicz, M.; Bradbury, P.; Ellis, P.; Laskin, J.; Kollmannsberger, C.; Hao, D.; Juergens, R.; Goss, G.; Wheatley-Price, P.; Hotte, S.; Gelmon, K.; Tinker, A.; Brown-Walker, P.; Gauthier, I.; Tu, D.; Song, X.; Seymour, L.
Journal: EUROPEAN JOURNAL OF CANCER Volume 103
Date of Publication:2018
Abstract:
.